Cara Therapeutics Inc (CARA) Kelajakdagi narxning foydaga nisbati

Cara Therapeutics Inc. (CARA) kompaniyasining rasmiy ramzlari

Cara Therapeutics, Inc. (CARA) uchun 12 oylik forward P/E ko'rsatkichi aktivning baholash dinamikasini aks ettiradi va ushbu metrika 0.00 miqdoriga yetdi. Cara Therapeutics, Inc. (CARA) moliyaviy barqarorligi buyrak qichishishini davolashdan olinadigan royalti to'lovlariga asoslangan bo'lib, bu xarajatlarni minimallashtiradi. Optimallashtirilgan xomashyo ta'minoti zanjirlari sinovlardagi uzilishlarning oldini oladi, garchi rahbariyat hozirda asosiy aktivlari uchun ishlab chiqish strategiyasini qayta ko'rib chiqayotgan bir paytda xarajatlarni jadal qisqartirayotgan bo'lsa-da.

CARA - Cara Therapeutics Inc. Forvard P/E multiplikatori 04.07.2022 - 18.11.2026 oraligʻida

Cara Therapeutics, Inc. (CARA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Fundamental baholash:caratherapeutics.com
Cara Therapeutics Inc tovar namunasi

Cara Therapeutics, Inc. (CARA) tomonidan innovatsion dori vositalarining ishlab chiqilishi geosiyosiy beqarorlik tufayli murakkablashmoqda, bu esa xalqaro klinik sinovlarga to'sqinlik qiladi va biomateriallar logistikasini buzadi. Kompaniyaning forward P/E koeffitsiyenti tarixini tahlil qilish orqali investor joriy bozor kapitalizatsiyasini prognoz qilingan daromadlar bilan bog'laydi, bu esa ortiqcha to'lov risklarini va tashqi shoklarning uzoq muddatli biznes daromadliligiga ta'sirini hisobga olgan holda aktivning adolatli qiymatini baholash imkonini beradi.

Cara Therapeutics, Inc. (CARA) raqobatchilari

Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Kelajakdagi narxning foydaga nisbati|Supernus Corp - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Corp)|BHVN - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Kelajakdagi narx-foyda multiplikatori TRVI|PRAX - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Anavex Life Sciences AVXL|CBLL: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Prothena Corporation PLC|ALEC (alector.com) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Annexon, Inc. (ANNX)|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|Neurogene Inc. - Narxning kelajakdagi foydaga nisbati|acimmune.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Forvard narx-foyda multiplikatori Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati ACOG|Kelajakdagi narxning foydaga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati SAVA (Cassava)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forvard P/E multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Prognoz qilingan narxning foydaga nisbati|CRVO (CervoMed, Inc.) - Prognoz qilingan narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Alterity Therapeutics Ltd|Kelajakdagi narxning foydaga nisbati Clene Inc.|PepGen Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati JUNS (Jupiter Neurosciences Inc)|Kelajakdagi narxning foydaga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - Forvard P/E multiplikatori|Klotho Neurosciences (KLTO) - Prognoz qilingan narxning foydaga nisbati|NeuroSense Therapeutics, Ltd. (NRSN) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forvard P/E multiplikatori|NRXS: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori HSDT|Forvard P/E multiplikatori Passage Bio Inc. (PASG)|Kelajakdagi narxning foydaga nisbati bionomics.com.au NEUP|Forvard P/E multiplikatori Minerva Neurosciences Inc NERV|ATHA: Prognoz qilingan narxning foydaga nisbati|ADXN (Addex Therapeutics, Ltd.) - Narxning kelajakdagi foydaga nisbati|Alzamend Neuro Inc. (ALZN) - Kelajakdagi narxning foydaga nisbati|Cyclerion - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati protagenic.com|Pasithea Therapeutics - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati CRGT (Cortigent, Inc.)|Avenue Therapeutics - Narxning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati Brainstorm Cell BCLI|CHRO - Prognoz qilingan narxning foydaga nisbati|ELYM: Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Kelajakdagi narxning foydaga nisbati|Marinus - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NKGen Biotech Inc|NRBO: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neurotrope|Kelajakdagi narxning foydaga nisbati Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Prognoz qilingan narx-foyda nisbati|WENA: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Therapeutics)